CompletedPhase 4

Paracervical Block for Pain Control in First Trimester Abortion

United States121 participantsStarted 2010-04

Plain-language summary

Many woman undergoing a surgical abortion receive a paracervical nerve block for pain reduction, in which lidocaine (a numbing medication) is injected around the cervix. These injections numb the cervix and possibly the lower part of the uterus. However, the injection can be uncomfortable and it is not well known whether it is effective in reducing pain. The purpose of this study is to determine the level of pain women experience with a surgical abortion and the effect that paracervical block might have on that pain.

Who can participate

Age range18 Years – 60 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age: 18 years or older * Voluntarily requesting pregnancy termination * Ultrasound confirmed intrauterine pregnancy up to 10 6/7 weeks gestational age * Good general health * English or Spanish speaking * Be able and willing to sign an informed consent and agree to terms of the study Exclusion Criteria: * Gestational ages over 11 0/7 weeks, due to routine misoprostol use at our institutions * Incomplete abortion * Required or requested narcotics or IV sedation (prior to randomization) * Patients who refuse Ibuprofen and paracervical blocks * Contraindications or allergies to lidocaine, ibuprofen or ativan * Significant physical or mental health condition * Adnexal mass or tenderness on pelvic exam consistent with pelvic inflammatory disease * Patients with known hepatic disease * Women, who in the opinion of the investigator are not suitable for the study protocol

What they're measuring

Pain reported with cervical dilation

Timeframe: 1 Year

Trial details

NCT IDNCT01094366

SponsorOregon Health and Science University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2010-10